智通财经APP获悉，鹰瞳科技-B(02251)涨超12%，截至发稿，涨11.13%，报12.78港元，成交额140.26万港元。
消息面上，2月7日，鹰瞳Airdoc宣布自主研发的万语医疗大模型完成焕新升级，并接入DeepSeek R1模型。据悉，公司24年7月布局鹰瞳万语医疗大模型，并于25年2月升级接入DeepSeek R1大模型，显著提升临床诊断效率和准确率，提供更专业的报告解读和更个性化的患者健康管理体验。
中信建投指出，鹰瞳科技是国内第一家获得NMPA批准人工智能三类辅助诊断注册证的企业。公司作为全球人工智能视网膜影像识别领域的领导者和先行者，致力于运用人工智能科研技术，提供慢病早筛管理和眼健康等诊疗一体化人工智能解决方案。鹰瞳科技主要产品Airdoc-AIFUNDUS 1.0获得国家药监局首张眼底人工智能辅助诊断三类医疗器械证书，旨在辅助诊断糖尿病视网膜病变，以协助医生做医疗诊断。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.